Want to see PHAR full AI Analyst Report?
Pharming Group (PHAR) Q2 2025 Earnings Report
PHAR Q2 2025 EPS Results
- Actual EPS
- $0.06
- Consensus EPS
- -$0.11
- Beat/Miss
- Beat by +$0.16
- One Year Ago EPS
- -$0.02
PHAR Q2 2025 Revenue Results
- Actual Revenue
- $94.45M
- Expected Revenue
- $82.63M
- Beat/Miss
- Beat by +$11.82M
- YoY Revenue Growth
- +27.58%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 07/31/2025
- Time
- Before Open
- Conference Call
- Thursday, July 31, 2025
PHAR Upcoming Earnings
Pharming Group's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
PHAR Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
PHAR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | 0.10- | 0.07 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 0.210.30 | 0.1 | 200.00% (+0.20) | |
| Jul 30, 2026 | 2026 (Q2) | 0.060.02 | 0.06 | -66.67% (-0.04) | |
| May 07, 2026 | 2026 (Q1) | 0.00-0.07 | -0.22 | 68.18% (+0.15) | |
| Mar 12, 2026 | 2025 (Q4) | 0.010.07 | 0.05 | 40.00% (+0.02) | |
| Nov 06, 2025 | 2025 (Q3) | 0.000.10 | -0.02 | 600.00% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | -0.100.06 | -0.02 | 400.00% (+0.08) | |
| May 08, 2025 | 2025 (Q1) | -0.03-0.22 | -0.19 | -15.79% (-0.03) | |
| Mar 13, 2025 | 2024 (Q4) | 0.020.05 | -0.04 | 225.00% (+0.09) | |
| Oct 24, 2024 | 2024 (Q3) | -0.00-0.02 | 0.01 | -500.00% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
